CANBridge Life Sciences
Suite 303A, Building E, Wangjing Pioneer Park, No.
Chaoyang District
Beijing
100102
China
Tel: 86-10-84148018
Fax: 86-10-84148017
Website: http://www.canbridgepharma.com/
Email: info@canbridgepharma.com
46 articles about CANBridge Life Sciences
-
Apogenix Reports Significant Progress In Collaboration With CANBridge Life Sciences
11/4/2016
-
First Patient Dosed In CANBridge Life Sciences’s CAN-008 Phase I/II Trial In Newly-Diagnosed Glioblastoma Multiforme In Taiwan
9/26/2016
-
CANBridge Life Sciences Signs Agreement With Boehringer Ingelheim To Manufacture Inhibitory Antibody, CAN-017, For Esophageal Squamous Cell Cancer
8/11/2016
-
CANBridge Life Sciences’s CAN-008 Approved For Phase I/II Trial In Newly-Diagnosed Glioblastoma Multiforme In Taiwan
7/26/2016
-
CANBridge Life Sciences Submits Investigational New Drug Application To Taiwan Food And Drug Administration For CAN-008 Phase I/II Trial In Glioblastoma
4/7/2016
-
AVEO Oncology, CANBridge Life Sciences Strike $134 Million Deal for AV-203
3/21/2016